By Ken Dropkiewski The bioresorbable stent was approved for use by the FDA in July of 2016. The Absorb GT1 Bioresorbable Vascular Scaffold System, manufactured by Abbott, was all set to solve a litany of the problems inherent with conventional […]
Tag: Abbott
Late-Breaking Data on Abbott’s MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease
WASHINGTON, March 18, 2017 /PRNewswire/ — Abbott (ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the United States. MitraClip treats people with degenerative […]